78 results
S-3
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
determine the amount of such consideration by approving a formula. In the absence of actual fraud in the transaction, the judgment of the directors
S-3
EX-5.1
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
of fraud or mutual mistake of fact or law or any other arrangements, agreements, understandings or course of conduct or prior or subsequent dealings … not and will not be any bad faith, breach of duty, breach of trust, fraud, coercion, duress or undue influence on the part of any of the directors of the Company
S-3
EX-1.2
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
. data privacy and securities laws and U.S. health care fraud and abuse laws, except where noncompliance would not, individually or in the aggregate … Health Service Act (42 U.S.C. §§ 262 et seq.); (ii) all applicable federal, state, local and foreign healthcare related fraud and abuse laws, including
10-Q
2024 Q1
EX-31.2
MREO
Mereo Biopharma Group Plc
15 May 24
Quarterly report
4:19pm
financial information; and
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s
10-Q
2024 Q1
EX-31.1
MREO
Mereo Biopharma Group Plc
15 May 24
Quarterly report
4:19pm
financial information; and
Any fraud, whether or not material, that involves management or other employees who have a significant role
10-K
EX-10.30
t4kpp
27 Mar 24
Annual report
5:20pm
10-K
1jxo9v uu
27 Mar 24
Annual report
5:20pm
10-K
EX-31.2
9xqsqpsbb
27 Mar 24
Annual report
5:20pm
10-K
EX-31.1
apicbt
27 Mar 24
Annual report
5:20pm